Tag: Global antibiotic resistance initiatives

A Glasgow professor's company, Glox Therapeutics, has received a significant boost in funding to continue its efforts in combating antimicrobial resistance (AMR) to antibiotics. The £1 million grant from Pathways to Antimicrobial Clinical Efficacy...